Related Experiment Videos
[Molecular analysis of multiple myeloma cells]
1First Department of Internal Medicine, Tokyo Medical and Dental University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 1, 1995
Summary
This study investigated oncogenes and suppressor genes in multiple myeloma (MM). Findings show these genes are involved in MM development and progression, with specific mutations identified in patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow.
- Understanding the molecular underpinnings of MM is crucial for developing targeted therapies.
Purpose:
- To analyze the role of specific oncogenes (c-myc, N-ras, K-ras) and the tumor suppressor gene (p53) in the pathogenesis of multiple myeloma.
- To identify the frequency and patterns of genetic alterations in these key genes within MM patients.
Summary:
- Elevated c-myc mRNA expression is common in MM, though gene rearrangements are rare.
- Mutations in N-ras and K-ras genes occur in approximately one-third of MM patients.
- p53 gene mutations are found in 10-20% of MM patients, often during advanced or leukemic stages.
Impact:
- These findings highlight the involvement of oncogenes and suppressor genes in both the initiation and advancement of multiple myeloma.
- Provides a molecular basis for understanding MM progression and suggests potential therapeutic targets.